BioGend Therapeutics Co., Ltd.(TW:6733)
NT$20.10-0.30 (-1.47%)
TW:6733
BioGend Therapeutics Co., Ltd. earnings date
NT$20.10
At close:-0.30 (-1.47%)
BioGend Therapeutics Co., Ltd. (6733) Q2 2024 Earnings Report
TW:6733 Q2 2024 EPS Results
- Actual EPS
- -TWD 0.28
- Consensus EPS
- -TWD 0.28
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -TWD 0.26
TW:6733 Q2 2024 Revenue Results
- Actual Revenue
- TWD 37.27M
- Expected Revenue
- TWD 37.00M
- Beat/Miss
- Beat by +TWD 266.00K
- YoY Revenue Growth
- -3.12%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2024
TW:6733 Upcoming Earnings
BioGend Therapeutics Co., Ltd.'s next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
TW:6733 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | ―- | -0.18 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―-0.17 | -0.06 | -198.21% (-0.11) | |
| May 06, 2026 | 2026 (Q1) | -0.13-0.13 | -0.27 | 52.06% (+0.14) | |
| Feb 24, 2026 | 2025 (Q4) | -0.10-0.18 | -0.32 | 43.40% (+0.14) | |
| Nov 06, 2025 | 2025 (Q3) | -0.09-0.06 | -0.25 | 77.51% (+0.19) | |
| Aug 07, 2025 | 2025 (Q2) | -0.18-0.19 | -0.28 | 32.26% (+0.09) | |
| May 07, 2025 | 2025 (Q1) | -0.16-0.27 | -0.09 | -196.67% (-0.18) | |
| Feb 25, 2025 | 2024 (Q4) | -0.23-0.32 | -0.26 | -20.91% (-0.06) | |
| Nov 08, 2024 | 2024 (Q3) | -0.25-0.25 | -0.36 | 30.64% (+0.11) | |
| Aug 08, 2024 | 2024 (Q2) | -0.28-0.28 | -0.26 | -9.41% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

